We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Falciparum malaria semi-resistant to clindamycin.
- Authors
Hall, A P; Doberstyn, E B; Nanokorn, A; Sonkom, P
- Abstract
Clindamycin, a semi-synthetic antibiotic of the lincomycin family, at a dose of 450 mg eight-hourly for three days in adults cured five out of 10 patients moderately ill with chloroquine-resistant falciparum malaria. Combination therapy with full-dose quinine and clindamycin for three days cured all four patients so treated who were followed up, and with half dosage three out of five patients were cured. Both combinations, however, caused upper gastrointestinal toxicity and appeared to potentiate both toxicity and possibly antimalarial efficacy. Colitis due to clindamycin was not observed. Sequential therapy was not toxic and could be useful in patients who have relapsed after more conventional treatment.
- Publication
British medical journal, 1975, Vol 2, Issue 5961, p12
- ISSN
0007-1447
- Publication type
Journal Article
- DOI
10.1136/bmj.2.5961.12